Patent assignee · US · COMPANY

Galera Labs, LLC

22Patents
22Active
22Granted
48Portfolio score

Filing activity: Oct 12, 2007 → Nov 30, 2021 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US10597415B2 Pentaaza macrocyclic ring complexes possessing oral bioavailability Human Necessities 7 Active
US9855279B2 Methods of treating oral mucositis Human Necessities 7 Active
US9149483B2 Methods for treatment of diseases Human Necessities 6 Active
US9738669B2 Pentaaza macrocyclic ring complexes possessing oral bioavailability Human Necessities 5 Active
US9642861B2 Methods of treating oral mucositis Human Necessities 5 Active
US10137133B2 Methods for treatment of diseases Human Necessities 5 Active
US11246950B2 Combination cancer immunotherapy with pentaaza macrocyclic ring complex Chemistry; Metallurgy 5 Active
US11219614B2 Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound Human Necessities 5 Active
US11066433B2 Pentaaza macrocyclic ring complexes possessing oral bioavailability Human Necessities 5 Active
US10493081B2 Methods for treatment of diseases Human Necessities 5 Active
US9738670B2 Pentaaza macrocyclic ring complexes possessing oral bioavailability Human Necessities 5 Active
US10610533B2 Methods of treating oral mucositis Human Necessities 4 Active
US9198893B2 Combination antitumor therapy Human Necessities 4 Active
US11612608B2 Methods of treating oral mucositis Human Necessities 3 Active
US9353069B2 Super-oxide dismutase mimetics Chemistry; Metallurgy 2 Active
US9150837B2 Polyethylene glycolated superoxide dismutase mimetics Physics 1 Active
US10350193B2 Super-oxide dismutase mimetics Chemistry; Metallurgy 1 Active
US11826373B2 Methods for treatment of diseases Human Necessities 1 Active
US12077549B2 Pentaaza macrocyclic ring complexes possessing oral bioavailability Human Necessities 0 Active
US12220420B2 Combination therapy for cancer treatment Human Necessities 0 Active
US9222922B2 Chromatography of metal complexes Physics 0 Active
US12156863B2 Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.